NCT03771235

Brief Summary

Tourette Syndrome (TS) and Persistent Tic Disorder (PTD) are chronic and potentially disabling neurobiological conditions. Although a range of pharmacological and psychosocial treatments exists, a significant number of individuals either do not respond to the current treatments or find them unacceptable. Thus, it is essential that researchers continue to develop and test novel treatment approaches. In this randomized controlled trial the investigators will compare two different online group-based interventions for tics: a mindfulness-based program (Mindfulness-based Intervention for Tics (MBIT), and a psychoeducational and supportive therapy program (Tic Information and Coping Strategies (TICS)). The purpose of this study is to determine which intervention is more helpful for adults with a tic disorder.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 9, 2018

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

December 7, 2018

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 11, 2018

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 2, 2020

Completed
Last Updated

April 29, 2024

Status Verified

April 1, 2024

Enrollment Period

2.1 years

First QC Date

December 7, 2018

Last Update Submit

April 25, 2024

Conditions

Keywords

Tourette SyndromeTic DisorderOnlineAdultsMindfulnessTherapy

Outcome Measures

Primary Outcomes (1)

  • Change in Yale Global Tic Severity Scale (YGTSS) Total Tic Severity Score

    Clinician-rated measure of tic severity

    Screening, Week 0, Week 9, Week 13, Week 35

Secondary Outcomes (16)

  • Clinical Global Impressions Scale

    Weeks 0, 9, 13, 35

  • Adult Tic Questionnaire

    Weeks 0, 9, 13, 35

  • Yale-Brown Obsessive Compulsive Scale

    Weeks 0, 9, 13, 35

  • Attention-Deficit Hyperactivity Rating Scale

    Weeks 0, 9, 13, 35

  • Depression Anxiety Stress Scale

    Weeks 0, 9, 13, 35

  • +11 more secondary outcomes

Study Arms (2)

Mindfulness-based Intervention for Tics

EXPERIMENTAL

8-week group-based mindfulness-based program

Behavioral: Mindfulness-based Intervention for Tics

Tic Information and Coping Strategies

ACTIVE COMPARATOR

8-week group-based educational and supportive therapy program

Behavioral: Tic Information and Coping Strategies

Interventions

Psychological intervention that focuses on cultivating awareness of urges to tic and developing a different relationship to those urges through meditation and other mindfulness practices.

Mindfulness-based Intervention for Tics

Psychological Intervention that focuses on learning more about tics, practicing a range of strategies for coping with tics (e.g., relaxation, effective communication), and discussing challenges commonly experienced by individuals with tics.

Tic Information and Coping Strategies

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • be 18 years of age or older,
  • possess a primary diagnosis of Tourette Syndrome or Persistent Tic Disorder,
  • be fluent in English
  • reside in the United States,
  • either not be taking any tic suppressant medication or other psychotropic medication or be at a stable dose for 8 weeks prior to the baseline assessment and throughout the study

You may not qualify if:

  • be receiving concurrent psychotherapy for the duration of the study
  • have prior extensive experience with mindfulness and/or meditation and
  • have another medical or psychological condition that would prevent the individual from fully engaging in the study or require a higher level of care (e.g., suicidality).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Bowdoin College

Brunswick, Maine, 04011, United States

Location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Tourette SyndromeTic Disorders

Interventions

Coping Skills

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesNeurodevelopmental DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Hannah Reese, Ph.D.

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 7, 2018

First Posted

December 11, 2018

Study Start

November 9, 2018

Primary Completion

December 2, 2020

Study Completion

December 2, 2020

Last Updated

April 29, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations